Angiotensin-Converting Enzyme Inhibition Attenuates Hypofibrinolysis and Reduces Cardiac Perivascular Fibrosis in Genetically Obese Diabetic Mice

Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk Patients

(2000) · New England Journal of Medicine · doi:10.1056/nejm200001203420301 · Cited by 8,663 · see citing works

Mortality from Coronary Heart Disease in Subjects with Type 2 Diabetes and in Nondiabetic Subjects with and without Prior Myocardial Infarction

Haffner, S. M., Lehto, S., Rönnemaa, T., Pyörälä, K., & Laakso, M. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807233390404 · Cited by 7,000 · see citing works

Cutaneous Wound Healing

Singer, A. J., & Clark, R. A. F. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909023411006 · Cited by 6,106 · see citing works

Role of oxidative stress in diabetic complications: a new perspective on an old paradigm.

Baynes, J. W., & Thorpe, S. R. (1999) · Diabetes · doi:10.2337/diabetes.48.1.1 · Cited by 2,441 · see citing works

Matrix metalloproteinases in angiogenesis: a moving target for therapeutic intervention

Stetler‐Stevenson, W. G. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6870 · Cited by 845 · see citing works

Matrix Metalloproteinases Regulate Neovascularization by Acting as Pericellular Fibrinolysins

Hiraoka, N., Allen, E. D., Apel, I. J., Gyetko, M. R., & Weiss, S. J. (1998) · Cell · doi:10.1016/s0092-8674(00)81768-7 · Cited by 711 · see citing works

Effect of Diabetes Mellitus on Formation of Coronary Collateral Vessels

Abacı, A., Oğuzhan, A., Kahraman, S., Eryol, N. K., Ünal, S., Arınç, H., & Ergin, A. (1999) · Circulation · doi:10.1161/01.cir.99.17.2239 · Cited by 626 · see citing works

Angiotensin II regulates the expression of plasminogen activator inhibitor-1 in cultured endothelial cells. A potential link between the renin-angiotensin system and thrombosis.

Vaughan, D. E., Lazos, S. A., & Tong, K. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117809 · Cited by 528 · see citing works

Troglitazone Improves Defects in Insulin Action, Insulin Secretion, Ovarian Steroidogenesis, and Fibrinolysis in Women with Polycystic Ovary Syndrome¹

Ehrmann, D. A., Schneider, D. J., Sobel, B. E., Cavaghan, M. K., Imperial, J., Rosenfield, R. L., & Polonsky, K. S. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.7.4069 · Cited by 461 · see citing works

Angiotensin II inhibits insulin signaling in aortic smooth muscle cells at multiple levels. A potential role for serine phosphorylation in insulin/angiotensin II crosstalk.

Folli, F. B., Kahn, C. R., Hansen, H. F., Bouchie, J. L., & Feener, E. P. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119752 · Cited by 424 · see citing works

Factors Responsible for Impaired Fibrinolysis in Obese Subjects and NIDDM Patients

McGill, J. B., Schneider, D. J., Arfken, C. L., Lucore, C. L., & Sobel, B. E. (1994) · Diabetes · doi:10.2337/diab.43.1.104 · Cited by 310 · see citing works

Angiotensin induction of PAI-1 expression in endothelial cells is mediated by the hexapeptide angiotensin IV.

Kerins, D. M., Hao, Q., & Vaughan, D. E. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118312 · Cited by 304 · see citing works

Increased Plasminogen Activator Inhibitor Type 1 in Coronary Artery Atherectomy Specimens From Type 2 Diabetic Compared With Nondiabetic Patients

Sobel, B. E., Woodcock‐Mitchell, J., Schneider, D. J., Holt, R. E., Marutsuka, K., & Gold, H. K. (1998) · Circulation · doi:10.1161/01.cir.97.22.2213 · Cited by 270 · see citing works

Effects of Ramipril on Plasma Fibrinolytic Balance in Patients With Acute Anterior Myocardial Infarction

Vaughan, D. E., Rouleau, J. L., Ridker, P. M., Arnold, J. M. O., Menapace, F. J., & Pfeffer, M. A. (1997) · Circulation · doi:10.1161/01.cir.96.2.442 · Cited by 264 · see citing works

Fibrin deposition in tissues from endotoxin-treated mice correlates with decreases in the expression of urokinase-type but not tissue-type plasminogen activator.

Yamamoto, K., & Loskutoff, D. J. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118691 · Cited by 198 · see citing works

Early Induction of Transforming Growth Factor-β via Angiotensin II Type 1 Receptors Contributes to Cardiac Fibrosis Induced by Long-term Blockade of Nitric Oxide Synthesis in Rats

Tomita, H., Egashira, K., Ohara, Y., Takemoto, M., Koyanagi, M., Katoh, M., Yamamoto, H., Tamaki, K., Shimokawa, H., & Takeshita, A. (1998) · Hypertension · doi:10.1161/01.hyp.32.2.273 · Cited by 191 · see citing works

Angiotensin II increases plasminogen activator inhibitor type 1 and tissue-type plasminogen activator messenger RNA in cultured rat aortic smooth muscle cells.

van Leeuwen, R. T. J., Kol, A., Andreotti, F., Kluft, C., Maseri, A., & Sperti, G. (1994) · Circulation · doi:10.1161/01.cir.90.1.362 · Cited by 173 · see citing works

Increased Plasminogen Activator Inhibitor-1 and Vasculopathy

Sobel, B. E. (1999) · Circulation · doi:10.1161/01.cir.99.19.2496 · Cited by 159 · see citing works

Plasma Leptin Level Is Associated With Myocardial Wall Thickness in Hypertensive Insulin-Resistant Men

Paolisso, G., Tagliamonte, M. R., Galderisi, M., Zito, G. A., Petrocelli, A., Carella, C., DIVITIIS, O. D., & Varricchio, M. (1999) · Hypertension · doi:10.1161/01.hyp.34.5.1047 · Cited by 156 · see citing works

Activation of Tissue Factor–Induced Coagulation and Endothelial Cell Dysfunction in Non–Insulin-Dependent Diabetic Patients With Microalbuminuria

Kario, K., Matsuo, T., Kobayashi, H., Matsuo, M., Sakata, T., & Miyata, T. (1995) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.15.8.1114 · Cited by 149 · see citing works

CalDAG-GEFIII Activation of Ras, R-Ras, and Rap1

Yamashita, S., Mochizuki, N., Ohba, Y., Tobiume, M., Okada, Y., Sawa, H., Nagashima, K., & Matsuda, M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003414200 · Cited by 143 · see citing works

Retinopathy Identifies Marked Restriction of Coronary Flow Reserve in Patients With Diabetes Mellitus

Akasaka, T., Yoshida, K., Hozumi, T., Takagi, T., Kaji, S., Kawamoto, T., Morioka, S., & Yoshikawa, J. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00242-8 · Cited by 140 · see citing works

Tissue factor gene expression in the adipose tissues of obese mice

Samad, F., Pandey, M., & Loskutoff, D. J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.13.7591 · Cited by 132 · see citing works

Angiotensin II Increases Plasminogen Activator Inhibitor-1 and Tissue Factor mRNA Expression without Changing that of Tissue Type Plasminogen Activator or Tissue Factor Pathway Inhibitor in Cultured Rat Aortic Endothelial Cells

Nishimura, H., Tsuji, H., Masuda, H., Nakagawa, K., Nakahara, Y., Kitamura, H., Kasahara, T., Sugano, T., Yoshizumi, M., Sawada, S., et al. (1997) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1656136 · Cited by 130 · see citing works

Troglitazone Improves Defects in Insulin Action, Insulin Secretion, Ovarian Steroidogenesis, and Fibrinolysis in Women With Polycystic Ovary Syndrome

Ehrmann, D. A., Schneider, D. J., Sobel, B. E., Cavaghan, M. K., Imperial, J., Rosenfield, R. L., & Polonsky, K. S. (1998) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-199801000-00017 · Cited by 129 · see citing works

Angiotensin II–Induced Transactivation of Epidermal Growth Factor Receptor Regulates Fibronectin and Transforming Growth Factor-β Synthesis via Transcriptional and Posttranscriptional Mechanisms

Moriguchi, Y., Matsubara, H., Mori, Y., Murasawa, S., Masaki, H., Maruyama, K., Tsutsumi, Y., Shibasaki, Y., Tanaka, Y., Nakajima, T., et al. (1999) · Circulation Research · doi:10.1161/01.res.84.9.1073 · Cited by 120 · see citing works

TNF-α and insulin, alone and synergistically, induce plasminogen activator inhibitor-1 expression in adipocytes

Sakamoto, T., Woodcock‐Mitchell, J., Marutsuka, K., Mitchell, J. J., Sobel, B. E., & Fujii, S. (1999) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1999.276.6.c1391 · Cited by 108 · see citing works

Tissue Factor Expression on Macrophages in Coronary Plaques in Patients with Unstable Angina

Kaikita, K., Ogawa, H., Yasue, H., Takeya, M., Takahashi, K., Saito, T., Hayasaki, K., Horiuchi, K., Takizawa, A., Kamikubo, Y., et al. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.17.10.2232 · Cited by 103 · see citing works

Insulin resistance in microvascular angina (syndrome X)

Bøtker, H. E., Bagger, J. P., Møller, N., Ovesen, P., Mengel, A., Schmitz, O., & Ørskov, H. (1993) · The Lancet · doi:10.1016/0140-6736(93)91344-l · Cited by 97 · see citing works

Induction of Plasminogen Activator Inhibitor Type 1 and Type 1 Collagen Expression in Rat Cardiac Microvascular Endothelial Cells by Interleukin-1 and Its Dependence on Oxygen-Centered Free Radicals

Okada, H., Woodcock‐Mitchell, J., Mitchell, J., Sakamoto, T., Marutsuka, K., Sobel, B. E., & Fujii, S. (1998) · Circulation · doi:10.1161/01.cir.97.21.2175 · Cited by 85 · see citing works

Angiotensin-Converting Enzyme Inhibitor Prevents Plasminogen Activator Inhibitor-1 Expression in a Rat Model with Cardiovascular Remodeling Induced by Chronic Inhibition of Nitric Oxide Synthesis

Katoh, M., Egashira, K., Mitsui, T., Chishima, S., Takeshita, A., & Narita, H. (2000) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.1999.1053 · Cited by 77 · see citing works

Pancreatic islet blood flow in normal and obese-hyperglycemic (ob/ob) mice

Carlsson, P., Andersson, A., & Jansson, L. E. (1996) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1996.271.6.e990 · Cited by 69 · see citing works

Collateral Circulation and Diabetes

Schaper, W. K. A., & Buschmann, I. R. (1999) · Circulation · doi:10.1161/01.cir.99.17.2224 · Cited by 66 · see citing works

Capillary surface area is reduced and tissue thickness from capillaries to myocytes is increased in the left ventricle of streptozotocin-diabetic rats

Warley, A., Powell, J. M., & Skepper, J. N. (1995) · Diabetologia · doi:10.1007/bf00410278 · Cited by 55 · see citing works

Inappropriate microvascular constriction produced transient ST-segment elevation in patients with syndrome X

Murakami, H., Urabe, K., & Nishimura, M. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00402-1 · Cited by 51 · see citing works

Augmentation of Arterial Endothelial Cell Expression of the Plasminogen Activator Inhibitor Type-1 (PAI-1) Gene by Proinsulin and Insulinin vivo

Nordt, T. K. (1998) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.1998.0719 · Cited by 50 · see citing works

Modulation of expression of monocyte/macrophage plasminogen activator activity and its implications for attenuation of vasculopathy.

Lundgren, C., Sawa, H., Sobel, B. E., & Fujii, S. (1994) · Circulation · doi:10.1161/01.cir.90.4.1927 · Cited by 45 · see citing works

The fat mouse: a powerful genetic model to study elevated plasminogen activator inhibitor 1 in obesity/NIDDM.

Samad, F., & Loskutoff, D. J. (1997) · PubMed · Cited by 38 · see citing works

The Fat Mouse: A Powerful Genetic Model to Study Elevated Plasminogen Activator Inhibitor 1 in Obesity/NIDDM

David, J. L., & Samad, F. (1997) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1657606 · Cited by 33 · see citing works

Cardiac remodeling in obesity

Abel, E. D., Litwin, S. E., & Sweeney, G. (2008) · Physiological Reviews · doi:10.1152/physrev.00017.2007 · Cited by 736 · see citing works

Diabetes-associated cardiac fibrosis: Cellular effectors, molecular mechanisms and therapeutic opportunities

Russo, I., & Frangogiannis, N. G. (2015) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2015.12.011 · Cited by 481 · see citing works

Obesity, metabolic dysfunction, and cardiac fibrosis: pathophysiological pathways, molecular mechanisms, and therapeutic opportunities

Cavalera, M., Wang, J., & Frangogiannis, N. G. (2014) · Translational research · doi:10.1016/j.trsl.2014.05.001 · Cited by 269 · see citing works

Adiponectin Protects Against Angiotensin II–Induced Cardiac Fibrosis Through Activation of PPAR-α

Fujita, K., Maeda, N., Sonoda, M., Ohashi, K., Hibuse, T., Nishizawa, H., Nishida, M., Hiuge, A., Kurata, A., Kihara, S., et al. (2008) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.107.156687 · Cited by 185 · see citing works

Cardiovascular effects of leptin

Sweeney, G. (2009) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2009.224 · Cited by 184 · see citing works

Endothelium Infection and Dysregulation by SARS-CoV-2: Evidence and Caveats in COVID-19

Bernard, I., Limonta, D., Mahal, L. K., & Hobman, T. C. (2020) · Viruses · doi:10.3390/v13010029 · Cited by 182 · see citing works

Local adipose tissue depots as cardiovascular risk factors

Thalmann, S., & MEIER, C. (2007) · Cardiovascular Research · doi:10.1016/j.cardiores.2007.03.008 · Cited by 162 · see citing works

Fibrosis of the diabetic heart: Clinical significance, molecular mechanisms, and therapeutic opportunities

Tuleta, I., & Frangogiannis, N. G. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113904 · Cited by 137 · see citing works

Increased Expression of Plasminogen Activator Inhibitor-1 in Cardiomyocytes Contributes to Cardiac Fibrosis after Myocardial Infarction

Takeshita, K., Hayashi, M., Iino, S., Kondo, T., Inden, Y., Iwase, M., Kojima, T., Hirai, M., Ito, M., Loskutoff, D. J., et al. (2004) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63135-5 · Cited by 122 · see citing works

Intramural Plasminogen Activator Inhibitor Type-1 and Coronary Atherosclerosis

Sobel, B. E., Taatjes, D. J., & Schneider, D. J. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000091250.53231.4d · Cited by 112 · see citing works

Weight regaining: From statistics and behaviors to physiology and metabolism

Anastasiou, C. A., Karfopoulou, E., & Yannakoulia, M. (2015) · Metabolism · doi:10.1016/j.metabol.2015.08.006 · Cited by 108 · see citing works

A Murine Model of Isolated Cardiac Steatosis Leads to Cardiomyopathy

Glenn, D. J., Wang, F., Nishimoto, M., Cruz, M., Uchida, Y., Holleran, W. M., Zhang, Y., Yeghiazarians, Y., & Gardner, D. G. (2011) · Hypertension · doi:10.1161/hypertensionaha.110.160655 · Cited by 96 · see citing works

Biomarkers of Obesity and Subsequent Cardiovascular Events

Musaad, S. M. A., & Haynes, E. N. (2007) · Epidemiologic Reviews · doi:10.1093/epirev/mxm005 · Cited by 90 · see citing works

Post‐transcriptional expression of DMT1 in the heart of rat

Ke, Y., Chen, Y. Y., Chang, Y. Z., Duan, X. L., Ho, K. P., Jiang, D. H., Wang, K., & Qian, Z. (2003) · Journal of Cellular Physiology · doi:10.1002/jcp.10284 · Cited by 89 · see citing works

Atherosclerotic-like process in aortic stenosis: Activation of the tissue factor–thrombin pathway and potential role through osteopontin alteration

Breyne, J., Juthier, F., Corseaux, D., Maréchaux, S., Zawadzki, C., Jeanpierre, E., Ung, A., Ennezat, P., Susen, S., BELLE, E. V., et al. (2010) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2010.07.047 · Cited by 78 · see citing works

Cardiovascular complications in diabetes mellitus

Sobel, B. E., & Schneider, D. J. (2005) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2005.01.002 · Cited by 75 · see citing works

Salutary effects of attenuation of angiotensin II on coronary perivascular fibrosis associated with insulin resistance and obesity

Zaman, A. K. M. T., Fujii, S., Goto, D., Furumoto, T., Mishima, T., Nakai, Y., Dong, J., Imagawa, S., Sobel, B. E., & Kitabatake, A. (2004) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2004.05.006 · Cited by 70 · see citing works

Platelet function, coagulopathy, and impaired fibrinolysis in diabetes

Sobel, B. E., & Schneider, D. J. (2004) · Cardiology Clinics · doi:10.1016/j.ccl.2004.06.009 · Cited by 65 · see citing works

Estrogen Deprivation and Replacement Modulate Cerebral Capillary Density With Vascular Expression of Angiogenic Molecules in Middle-Aged Female Rats

Jesmin, S., Hattori, Y., Sakuma, I., Liu, M., Mowa, C. N., & Kitabatake, A. (2003) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200302000-00005 · Cited by 64 · see citing works

Angiotensin II type 1 receptor blockers reduce tissue factor activity and plasminogen activator inhibitor type-1 antigen in hypertensive patients: a randomized, double-blind, placebo-controlled study

Koh, K. K., Chung, W., Ahn, J. Y., Han, S. H., Kang, W. C., Seo, Y., Ahn, T. H., Choi, I. S., & Shin, E. K. (2004) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2004.07.008 · Cited by 62 · see citing works

Expression of ferroportin1, hephaestin and ceruloplasmin in rat heart

Qian, Z., Chang, Y. Z., Leung, G., Du, J. R., Zhu, L., Wang, Q. L., Niu, L., Xu, Y. J., Yang, L., Ho, K. P., et al. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2007.02.006 · Cited by 53 · see citing works

Plasminogen Activator Inhibitor‐1: Physiologic Role, Regulation, and the Influence of Common Pharmacologic Agents

Tsikouris, J. P., Suarez, J. A., & Meyerrose, G. E. (2002) · The Journal of Clinical Pharmacology · doi:10.1177/009127002762491271 · Cited by 49 · see citing works

Intramuscular renin–angiotensin system is activated in human muscular dystrophy

Sun, G., Haginoya, K., Dai, H., Chiba, Y., Uematsu, M., Hino‐Fukuyo, N., Onuma, A., Iinuma, K., & Tsuchiya, S. (2009) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2009.01.020 · Cited by 48 · see citing works

Reduced cardiac expression of plasminogen activator inhibitor 1 and transforming growth factor β₁ in obese Zucker rats by perindopril

Toblli, J. E., Cao, G., DeRosa, G., & Forcada, P. (2005) · Heart · doi:10.1136/hrt.2003.022707 · Cited by 47 · see citing works

Circulating ACE is a predictor of weight loss maintenance not only in overweight and obese women, but also in men

Wang, P., Holst, J. J., Wodzig, W. K. W. H., Andersen, M. R., Astrup, A. V., van Baak, M. A., Larsen, T. M., Jebb, S. A., Kafatos, A., Pfeiffer, A. F. H., et al. (2012) · International Journal of Obesity · doi:10.1038/ijo.2011.278 · Cited by 46 · see citing works

Effect of Catheter Ablation on Progression of Paroxysmal Atrial Fibrillation

Jongnarangsin, K., Suwanagool, A., Chugh, A., Crawford, T. C., Good, E. D., Pelosi, F., Bogun, F. M., Oral, H., & Morady, F. (2011) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2011.02137.x · Cited by 43 · see citing works

ACE inhibitor and angiotensin type I receptor antagonist in combination reduce renal damage in obese Zucker rats

Toblli, J. E., DeRosa, G., Cao, G., Piorno, P., & Pagano, P. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00661.x · Cited by 43 · see citing works

Pathophysiological Association of Endothelial Dysfunction with Fatal Outcome in COVID-19

Maruhashi, T., & Higashi, Y. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22105131 · Cited by 40 · see citing works

Correlation of functional and structural alterations of the coronary arterioles during development of type II diabetes mellitus in rats

Yu, Y., OHMORI, K., KONDO, I., Yao, L., NOMA, T., TSUJI, T., Mizushige, K., & KOHNO, M. (2002) · Cardiovascular Research · doi:10.1016/s0008-6363(02)00513-8 · Cited by 40 · see citing works

Cardiac steatosis potentiates angiotensin II effects in the heart

Glenn, D. J., Cardema, M. C., Ni, W., Zhang, Y., Yeghiazarians, Y., Grapov, D., Fiehn, O., & Gardner, D. G. (2014) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00742.2014 · Cited by 38 · see citing works

Cardiac fibrosis and vascular remodeling are attenuated by metformin in obese rats

Burlá, A. K., Lobato, N. S., Fortes, Z. B., Oigman, W., & Neves, M. F. (2011) · International Journal of Cardiology · doi:10.1016/j.ijcard.2011.09.012 · Cited by 34 · see citing works

Angiotensin II Receptor Antagonist Attenuates Expression of Aging Markers in Diabetic Mouse Heart

Kosugi, R., Shioi, T., Watanabe-Maeda, K., Yoshida, Y., Takahashi, K., Machida, Y., & Izumi, T. (2006) · Circulation Journal · doi:10.1253/circj.70.482 · Cited by 34 · see citing works

Pharmacologic Blockade of the Renin‐Angiotensin System: Vascular Benefits Beyond Commonly Understood Pharmacologic Actions

Tsikouris, J. P., & Cox, C. D. (2003) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.23.10.1141.32763 · Cited by 33 · see citing works

Modulation of myocardial injury and collagen deposition following ischaemia–reperfusion by linagliptin and liraglutide, and both together

Wang, X., Ding, Z., Yang, F., Dai, Y., Chen, P., Theus, S. A., Singh, S. P., Budhiraja, M., & Mehta, J. L. (2016) · Clinical Science · doi:10.1042/cs20160061 · Cited by 33 · see citing works

A Profibrotic Effect of Plasminogen Activator Inhibitor Type-1 (PAI-1) in the Heart

Zaman, A. K. M. T., French, C. J., Schneider, D. J., & Sobel, B. E. (2009) · Experimental Biology and Medicine · doi:10.3181/0811-rm-321 · Cited by 33 · see citing works

Increased Expression of Plasminogen Activator Inhibitor-1 by Mediators of the Acute Phase Response: a Potential Progenitor of Vasculopathy in Hypertensives

Jie, D. O. N. G., Fujii, S., Goto, D., Furumoto, T., Kaneko, T., ZAMAN, T. A., Nakai, Y., Mishima, T., Imagawa, S., & Kitabatake, A. (2003) · Hypertension Research · doi:10.1291/hypres.26.723 · Cited by 33 · see citing works

Felodipine Reduces Cardiac Expression of IL-18 and Perivascular Fibrosis in Fructose-Fed Rats

Xing, S., Tan, H., Bi, X., Zhong, M., Zhang, Y., & Zhang, W. (2008) · Molecular Medicine · doi:10.2119/2008-00024.xing · Cited by 27 · see citing works

Deleterious effects of lack of cardiac PAI-1 after coronary occlusion in mice and their pathophysiologic determinants

Zaman, A. K. M. T., Fujii, S., Schneider, D. J., Taatjes, D. J., LIJNEN, H. R., & Sobel, B. E. (2007) · Histochemistry and Cell Biology · doi:10.1007/s00418-007-0300-z · Cited by 26 · see citing works

Combined therapy with ramipril and simvastatin has beneficial additive effects on tissue factor activity and prothrombin fragment 1+2 in patients with type 2 diabetes

Koh, K. K., Quon, M. J., Han, S. H., Ahn, J. Y., Lee, Y., & Shin, E. K. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.07.031 · Cited by 25 · see citing works

Effects of glycemic control and other determinants on vascular disease in type 2 diabetes

Sobel, B. E. (2002) · The American Journal of Medicine · doi:10.1016/s0002-9343(02)01277-9 · Cited by 23 · see citing works

Obesity and sudden cardiac death: Prevalence, pathogenesis, prevention and intervention

Yao, Y., Jia, X., & Li, B. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.1044923 · Cited by 25 · see citing works

Fibrinolysis and diabetes

Sobel, B. E. (2003) · Frontiers in bioscience · doi:10.2741/1140 · Cited by 21 · see citing works

Roles of p38-MAPK in Insulin Resistant Heart: Evidence from Bench to Future Bedside Application

Kumphune, S., Chattipakorn, S. C., & Chattipakorn, N. (2013) · Current Pharmaceutical Design · doi:10.2174/1381612811319320009 · Cited by 18 · see citing works

Increased plasminogen activator inhibitor type-1 (PAI-1) in the heart as a function of age

Sobel, B. E., Lee, Y., Pratley, R. E., & Schneider, D. J. (2006) · Life Sciences · doi:10.1016/j.lfs.2006.05.011 · Cited by 18 · see citing works

Insulin resistance increases PAI-1 in the heart

Sobel, B. E., Schneider, D. J., Lee, Y., & Pratley, R. E. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.05.078 · Cited by 18 · see citing works

Gender-specific genetic associations of polymorphisms in ACE, AKR1C2, FTO and MMP2 with weight gain over a 10-year period

Bouwman, F. G., Boer, J. M. A., Imholz, S., Wang, P., Verschuren, W. M. M., Dollé, M. E. T., & Mariman, E. C. M. (2014) · Genes & Nutrition · doi:10.1007/s12263-014-0434-2 · Cited by 17 · see citing works

Pharmacological and Clinical Studies with Temocapril, an Angiotensin Converting Enzyme Inhibitor that is Excreted in the Bile

Yasunari, K., Maeda, K., Nakamura, M., Watanabe, T., Yoshikawa, J., & Asada, A. (2004) · Cardiovascular Drug Reviews · doi:10.1111/j.1527-3466.2004.tb00140.x · Cited by 16 · see citing works

COVID-19, Endothelium and the Cardiometabolic Patient: A Possible Role for Capillary Leak Syndrome

Lambadiari, V., Korakas, E., Oikonomou, E. K., Bletsa, E., Kountouri, A., Goliopoulou, A., Ikonomidis, I., & Siasos, G. (2022) · Biomedicines · doi:10.3390/biomedicines10102379 · Cited by 12 · see citing works

Left ventricular remodelling impacts on coronary flow reserve in hypertensive patients: is there a vascular mechanism?

Jennings, G., & Dilley, R. J. (2002) · Journal of Hypertension · doi:10.1097/00004872-200207000-00013 · Cited by 11 · see citing works

Lercanidipine and Losartan Effects on Blood Pressure and Fibrinolytic Parameters

Lin, T., Voon, W., Yen, H., Huang, C., Su, H., Lai, W., & Sheu, S. (2006) · The Kaohsiung Journal of Medical Sciences · doi:10.1016/s1607-551x(09)70304-3 · Cited by 10 · see citing works

Diabetes and Atherosclerosis

Lopes-Virella, M. F., & Virella, G. (2005) · Humana Press eBooks · doi:10.1385/1-59259-908-7:225 · Cited by 7 · see citing works

Loss of insulin receptor substrate-1 signaling induces the cardiovascular and proteo(fibrino)lytic system derangements typical of insulin resistance

Furumoto, T., Fujii, S., Onozuka, H., Zaman, A. K. M. T., Goto, D., Sugawara, T., Mikami, T., Watanabe, S., Abe, K., Terauchi, Y., et al. (2005) · Coronary Artery Disease · doi:10.1097/00019501-200503000-00007 · Cited by 6 · see citing works

EFFECT OF CATHETER ABLATION ON PROGRESSION OF PAROXYSMAL ATRIAL FIBRILLATION

Suwanagool, A., Chugh, A., Crawford, T. C., Good, E. D., Pelosi, F., Bogun, F. M., Oral, H., Morady, F., & Jongnarangsin, K. (2011) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(11)60130-7 · Cited by 4 · see citing works

Cardiac Fibroblast

Park, J., & Tallquist, M. D. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809657-4.99828-4 · Cited by 4 · see citing works

ACE Inhibitors: Pharmacology

Gohlke, P., & A., B. (2004) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-18497-0_17 · Cited by 3 · see citing works

Renin-Angiotensin-Aldosterone System in Diabetic Cardiovascular Complications

Balakrishnan, V. S. (2023) · Contemporary cardiology · doi:10.1007/978-3-031-13177-6_31 · Cited by 2 · see citing works

Resveratrol protects against early cardiomyopathic changes-induced by Type-1 diabetes through a heme-oxygenase-1 dependent mechanism

Hammad, A. S. A., Ahmed, A. F., Heeba, G. H., & Taye, A. (2018) · Journal of advanced Biomedical and Pharmaceutical Sciences · doi:10.21608/jabps.2018.5175.1022 · Cited by 2 · see citing works

Diabetes and Atherosclerosis

Lopes-Virella, M. F., & Virella, G. (2023) · Contemporary cardiology · doi:10.1007/978-3-031-13177-6_9 · Cited by 2 · see citing works

The Renin—Angiotensin System in Diabetic Cardiovascular Complications

Feener, E. P. (2005) · Humana Press eBooks · doi:10.1385/1-59259-908-7:073 · Cited by 2 · see citing works

Diabetes and Heart Disease

Sobel, B. E. (2015) · Cardiovascular medicine · doi:10.1007/978-1-4471-2828-1_6 · Cited by 1 · see citing works

Protease Cathepsins in Cardiomyopathy: From Mechanism to Intervention

Guo, R., & Nair, S. (2017) · Springer eBooks · doi:10.1007/978-981-10-3162-5_21 · Cited by 1 · see citing works

Angiotensin-Converting Enzyme Inhibitor Ramipril Improves Coronary Microvascular Remodeling in Type II Diabetic Rats

Chang, K., Baek, S. H., Ko, S., Yoon, K., Kim, K. Y., Seung, K. B., Chae, J. S., Kim, J. H., Hong, S. J., & Choi, K. B. (2002) · Korean Circulation Journal · doi:10.4070/kcj.2002.32.8.680 · Cited by 1 · see citing works

Anti-thrombotic therapy for metabolic syndrome

Fujii, S. (2007) · Japanese Journal of Thrombosis and Hemostasis · doi:10.2491/jjsth.18.607

Obesity and Cardiac Dysfunction

Sweeney, G., Litwin, S. E., & Abel, E. D. (2010) · Springer eBooks · doi:10.1007/978-1-4419-1607-5_14

OBSOLETE: Cardiac Fibroblast

Tallquist, M. D. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.99828-3

Renin Angiotensin System in the Pathophysiology of Diabetic Cardiomyopathy in Type 2 Diabetes

Gomes, K. P., Jadli, A. S., & Patel, V. B. (2023) · Advances in biochemistry in health and disease · doi:10.1007/978-3-031-14952-8_15

Impacto do microRNA-22 na reatividade vascular da aorta de camundongos obesos.

Silva, C. S. B. (2022) · doi:10.11606/d.42.2022.tde-18082023-105033

Obesity-Associated Cardiac Fibrosis: Mechanisms and Emerging Therapeutic Targets

Zhou, D., Tan, Y., Zhao, J., Wang, S., Wang, Z., Bai, M., Niu, X., & Zhang, Z. (2026) · Vascular Health and Risk Management · doi:10.2147/vhrm.s567568

Salutary effects of attenuation of angiotensin II on coronary perivascular fibrosis associated with insulin resistance and obesity

Zaman, A. K. M. T., Fujii, S., Goto, D., Furumoto, T., Mishima, T., Nakai, Y., Dong, J., Imagawa, S., Sobel, B. E., & Kitabatake, A. (2004) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2004.05.006 · Cited by 70 · see citing works

Inhibition of angiotensin converting enzyme (ACE) attenuates hypofibrinolysis and reduces cardiac perivascular fibrosis in genetically obese mice

Zaman, A. K. M. T., Fujii, S., Goto, D., Ishimori, N., Watano, K., Kaneko, T., Furumoto, T., Sugawara, T., Sobel, B. E., & Kitabatake, A. (2002) · Journal of Molecular and Cellular Cardiology · doi:10.1016/s0022-2828(02)90354-8 · Cited by 2 · see citing works

Diminished Fibrinolysis and Thrombosis : Clinical Implications for Accelerated Atherosclerosis

Fujii, S., Goto, D., Zaman, T., Ishimori, N., Watano, K., Kaneko, T., Okada, H., Makiguchi, M., Nakagawa, T., & Kitabatake, A. (1998) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat1994.5.76 · Cited by 28 · see citing works

Angiotensin Converting Enzyme (ACE) Inhibition Attenuates Hypofibrinolysis and Reduces Cardiac Perivascular Fibrosis during Development of Diabetic Cardiomyopathy in Obese Mice

Zaman, A. K. M. T., Fujii, S., Gotoh, D., Furumoto, T., Sugawara, T., Mishima, T., Nakai, Y., Dong, J., Imagawa, S., Sobel, B. E., et al. (2003) · Japanese Circulation Journal-english Edition

2P-0402 Hypofibrinolysis and cardiac perivascular fibrosis observed during the development of diabetes in obese mice: Beneficial role of angiotensin converting enzyme (ACE) inhibitor

Zaman, A., Fujii, S., Goto, D., Furumoto, T., Imagawa, S., Jie, D., Mishima, T., Nakai, Y., Be, S., & Kitabatake, A. (2003) · Atherosclerosis Supplements · doi:10.1016/s1567-5688(03)90544-7